North America - United States • Industry focus
Benesch, Friedlander, Coplan & Aronoff LLP
We only have limited information for this firm. Consider the following firms which have provided more information:
The Benesch, Friedlander, Coplan & Aronoff LLP team’s cannabis expertise covers M&A and the structuring of investments, securities, litigation and arbitration, and the preparation of marijuana applications with state and municipal regulatory agencies and boards. It is frequently instructed by cannabis cultivators, processors, dispensaries, and traditional companies affected by cannabis laws. At the helm of the practice, Bryna Dahlin advises on issues of regulatory compliance, contracts and licensing, and intellectual property protection. She has additional expertise in litigation. Bill Doran specializes in M&A, private equity, and general corporate and commercial transactions, while Bob Morgan has a strong practice in regulatory compliance. All individuals mentioned are based in Chicago, with the exception of Cleveland-based Robert Zimmerman, who focuses on litigation.
Legal 500 Editorial commentary
Key clients
- TPCO Holdings Corp.
- Nuka/1906
Abbreviated data is displayed for this firm.
Work highlights
- Acted as lead corporate and intellectual property counsel to TPCO’s restructuring of its business relationships with Roc Nation and Sean (Jay-Z) Carter.
- Successfully petitioned the Ohio Board of Pharmacy to add a new product category—tablets for oral administration—allowing Nuka (dba1906) to return to the Ohio market, following the removal of all of its products from the Ohio market.
Abbreviated data is displayed for this firm.